November 01, 2025
Market insights predict the global biologics CDMO industry will increase from USD 22 billion in 2024 to USD 92.79 billion by 2034, achieving a CAGR of 15.48%. In 2024, North America led the biologics CDMO market with 37% share. Asia-Pacific is expect...
October 30, 2025
According to market projections, the biologics sector is expected to grow from USD 450.92 billion in 2024 to USD 938.04 billion by 2034, reflecting a CAGR of 7.6%. Biologics are advanced medicines made from living cells or organisms. They include vac...
November 13, 2025
According to market projections, the biologics contract research organization sector is expected to grow from USD 31.15 billion in 2024 to USD 106.28 billion by 2034, reflecting a CAGR of 13.04%.The market is growing due to the rising demand for biol...
November 01, 2025
Market insights predict, the biologics safety testing industry is expected to grow from USD 4.03 billion in 2024 to USD 14.45 billion by 2034, driven by a CAGR of 13.64%. The growing demand for biologics and growing research and development activitie...
October 10, 2025
Projections indicate that, the global Latin America life science market will increase from USD 4.49 billion in 2024 to USD 12.05 billion by 2034, experiencing a CAGR of 10.38% over the next 10 years. The market is expanding rapidly due to rising R&am...
November 01, 2025
The market is growing due to the rising prevalence of atopic diseases like dermatitis and asthma, coupled with increasing demand for advanced biologically targeted therapies. Growing awareness, better diagnostics, and expanding healthcare access are ...
November 01, 2025
According to market projections, the subcutaneous biologics sector is expected to grow from USD 1.89 billion in 2024 to USD 5.37 billion by 2034, reflecting a CAGR of 11.09%. The growing demand for self-administration and the need for targeted therap...
November 06, 2025
Based on market forecasts, the global drug repurposing market, projected at USD 636.95 million in 2025, is expected to reach USD 2506.64 million by 2035, growing at a CAGR of 14.76% over the forecast period. The world is demanding faster, more afford...
November 01, 2025
Market insights predict, the osteoarthritis therapeutics industry is expected to grow from USD 9.95 billion in 2024 to USD 24.52 billion by 2034, driven by a CAGR of 9.45%. The rising prevalence of osteoarthritis is estimated to drive the growth of t...
November 01, 2025
According to market projections, the global filtration in biologics market is fueled by growing demand for biologics such as vaccines and therapies for cancer and autoimmune disorders, and by boosting investments in R&D activities. Whereas, North...
November 01, 2025
According to market projections, the global cancer biologics market, valued at USD 110.91 billion in 2024, is anticipated to reach USD 232.02 billion by 2034, growing at a CAGR of 7.66% over the next decade. Rising cancer research is anticipated...
November 01, 2025
According to market projections, the global retinal biologics market, valued at USD 25.02 billion in 2024, is anticipated to reach USD 53.61 billion by 2034, growing at a CAGR of 7.92% over the next decade. The growing geriatric population drives the...
November 01, 2025
Market insights predict, the myasthenia gravis industry is expected to grow from USD 1.45 billion in 2024 to USD 2.95 billion by 2034, driven by a CAGR of 7.35%. In 2024, North America led the myasthenia gravis market, with Asia Pacific set for the f...
November 26, 2025
Projections indicate that, the global ankylosing spondylitis market will increase from USD 6.7 billion in 2025 to USD 11.83 billion by 2035, experiencing a CAGR of 5.85% over the next 10 years. The rising prevalence of autoimmune disorders and growin...
November 01, 2025
Based on market forecasts, the spine biologics sector will expand from USD 4.42 billion in 2024 to USD 7.34 billion by 2034, experiencing a CAGR of 5.20%. Key drivers of the market's expansion include the rising incidence of degenerative spine illnes...
November 01, 2025
Projections indicate that, the global pharmaceutical stability & storage services market will increase from USD 3.4 billion in 2024 to USD 5.92 billion by 2034, experiencing a CAGR of 5.7% over the next 10 years. The compliance with global standa...
November 01, 2025
The U.S. residual DNA testing market is growing because increasing application of this testing in forensics and criminal investigations, immigration, infidelity, and paternity....
November 01, 2025
Based on market forecasts, the global pharmaceutical logistic market, projected at USD 111.45 million in 2024, is expected to reach USD 191.1 million by 2034, growing at a CAGR of 5.54% over the forecast period. The demand for efficient and timely de...
November 01, 2025
Projections indicate that, the global immortalized cell line market will increase from USD 4.55 billion in 2024 to USD 8.68 billion by 2034, experiencing a CAGR of 6.71% over the next 10 years.The market is growing due to increasing demand for stable...
November 01, 2025
According to market projections, the cell culture sector is expected to grow from USD 20.61 billion in 2024 to USD 60.38 billion by 2034, reflecting a CAGR of 11.35%. The increasing incidences of chronic disorders, growing research and development,...
November 01, 2025
The next-generation therapy market is expanding due to increasing use of cell and gene therapies as well as rising developments in RNA-based therapies. North America led the market due to the robust industries....
November 01, 2025
According to forecasts, the global pharmaceutical drying equipment market will grow from USD 5.84 billion in 2024 to USD 11.64 billion by 2034, with an expected CAGR of 7.14%. Rising demand for biologics and vaccines is estimated to drive the growt...
November 01, 2025
The life science CDMO market is expanding due to it offers inclusive services from drug development through drug manufacturing, and it majorly focuses on affordability and sustainability by reducing the environmental impact, patient-centric approache...
November 01, 2025
Projections indicate that, sterile drug product testing industry is growing due to rising demand for injectable drugs and stricter regulatory requirements for product safety. Increased pharmaceutical and biologics production further fuels this growth...
November 01, 2025
Market insights predict, the orthopedic devices industry is expected to grow from USD 63.06 billion in 2024 to USD 96.45 billion by 2034, driven by a CAGR of 4.34%. The rising prevalence of orthopedic disorders and advancements in medical devices are...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com